checkAd
    Startseite > Aktien > Ikonisys > Nachrichten
    Ikonisys Aktie
    1,3500
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 08:04:40 Frankfurt
    1,3700
     
    EUR
    1.000 STK
    Geldkurs 09:00:07
    1,5100
     
    EUR
    1.000 STK
    Briefkurs 09:00:07
    ISIN: FR00140048X2 · WKN: A3CVR6 · SYM: 9W8 · Frankreich

    Neueste Nachrichten

    Ikonisys: Hospitex International to Partner With Allianz Value for First Large-Scale Screening Program Dedicated to Urinary Tract Oncology Diagnostics in Italy
    29.02.24 · Business Wire (engl.) · Ikonisys
    Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Ragusa
    19.02.24 · Business Wire (engl.) · Ikonisys
    Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
    06.02.24 · dpa-AFX · Ikonisys
    Ikonisys: New Production Record for Hospitex International
    02.01.24 · Business Wire (engl.) · Ikonisys
    Ikonisys Announces the Completion of a Private Placement to Speed up Growth Following Recent Pivotal Deals
    28.12.23 · Business Wire (engl.) · Ikonisys
    Ikonisys Announces a Partnership Between Hospitex International and the Pathologists Beyond Borders Association
    15.12.23 · Business Wire (engl.) · Ikonisys
    Ikonisys to Acquire Hospitex International and Become an Integrated Cancer Diagnostic Leader
    30.11.23 · Business Wire (engl.) · Ikonisys
    Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
    01.11.23 · dpa-AFX · Ikonisys
    Ikonisys and Biocare Medical Forge Alliance: Amplifying Global FISH Diagnostics with Advanced Fluorescent Scopes
    31.10.23 · Business Wire (engl.) · Ikonisys
    Ikonisys publishes its 2023 half-year financial results and reviews its operational and strategic deployments
    30.10.23 · Business Wire (engl.) · Ikonisys
    Ikonisys Successfully Completed Its ISO Certification Reaffirming Its Ability to Continuously Meet Quality International Standard Requirements
    16.10.23 · Business Wire (engl.) · Ikonisys
    Ikonisys SA: Successful Study in Collaboration With the Neag Cancer Center of UConn School of Medicine Demonstrates the Power of the Ikoniscope Platform for Detection of Extremely Rare Cells in the Field of Immuno-Oncology
    10.10.23 · Business Wire (engl.) · Ikonisys